Inflammatory mediators, such as interleukin (IL)-6, IL-8, IL-10 and tumor necrosis factor-α (TNFα), are increased in serum or plasma of CTEPH patients (7, 11, 12, 21–24). This evidence concerns the gene IL6 and chronic thromboembolic pulmonary hypertension.